Cadrenal Therapeutics, Inc. Common Stock (CVKD) Stock Analysis

Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a publicly traded company in the HEALTHCARE sector. It trades at $4.35, carries a market capitalization of $14.47M. This page summarizes the public market data, fundamentals, and frequently asked questions for CVKD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.35
• Market Cap: $14.47M
• EPS: $-5.59
• 52-Week High: $15.99
• 52-Week Low: $4.21

Market Sentiment

Cadrenal Therapeutics, Inc. Common Stock currently has a Neutral sentiment score of -0.02.

About Cadrenal Therapeutics, Inc. Common Stock

None

GNG Research Analysis

GNG Research scores Cadrenal Therapeutics, Inc. Common Stock (CVKD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CVKD.

Frequently Asked Questions

Does CVKD pay dividends?

Cadrenal Therapeutics, Inc. Common Stock (CVKD) does not currently pay a regular dividend.

What is CVKD's market cap?

Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a market capitalization of $14.47M with a current stock price of $4.35.